Crystalline forms of the CXCR7 receptor antagonist (3S,4S)-1-Cyclopropylmethyl-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-3-carboxylic acid (1-pyrimidin-2-yl-cyclopropyl)-amide
US-11339148-B2 · May 24, 2022 · US
Guerry Philippe is listed as an inventor on 12 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Guerry Philippe |
| Total patents | 12 |
| First publication | Nov 26, 2015 |
| Latest publication | May 24, 2022 |
Publications ranked by popularity score, then publication date.
US-11339148-B2 · May 24, 2022 · US
US-11306078-B2 · Apr 19, 2022 · US
US-2021115033-A1 · Apr 22, 2021 · US
US-2020385373-A1 · Dec 10, 2020 · US
US-10752620-B2 · Aug 25, 2020 · US
US-2019169180-A1 · Jun 6, 2019 · US
US-10202368-B2 · Feb 12, 2019 · US
US-9920010-B2 · Mar 20, 2018 · US
US-2017327493-A1 · Nov 16, 2017 · US
US-9428456-B2 · Aug 30, 2016 · US
Latest publications not already listed above.
US-2016107997-A1 · Apr 21, 2016 · US
US-2015336893-A1 · Nov 26, 2015 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Idorsia Pharmaceuticals Ltd | 9 |
| Actelion Pharmaceuticals Ltd | 5 |
Most common classification codes across this inventor's patents.